In order to meet the growing importance of precision oncological diagnostics and therapy, a “Molecular TumorBoard – MTB” was established at the CCC München LMU in 2016. In the meantime, the MTB forms the “Molecular Diagnostics and Therapy...
Based on the existing expertise in Bavaria, immuno-oncology is to be the first joint research focus of the BZKF. The aim is to prevent or detect significantly more cancers earlier and to be able to cure more cancers through new personalised and immunotherapeutic...
Recent Comments